MCMCB Pro
J0132

J0132Injection, acetylcysteine, 100 mg

HCPCSActiveBETOS O1E

J0132 is a HCPCS Level II code for injection, acetylcysteine, 100 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J0132 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
12 units
MAI 3 — Date of Service Edit: Clinical · Clinical: Data
outpatient
300 units
MAI 3 — Date of Service Edit: Clinical · Clinical: Data
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J0132

Long descriptor
Injection, acetylcysteine, 100 mg

The official wording. This is what the code means.

Short descriptor
Acetylcysteine injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2006

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0132

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0132 is not quite right, the correct code is very often within a few positions of it.

  • H2041Coordinated specialty care, team-based, for first episode psychosis, per encounter
  • J0013Esketamine, nasal spray, 1 mg
  • J0120Injection, tetracycline, up to 250 mg
  • J0121Injection, omadacycline, 1 mg
  • J0122Injection, eravacycline, 1 mg
  • J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0130Injection abciximab, 10 mg
  • J0131Injection, acetaminophen, not otherwise specified,10 mg
  • J0133Injection, acyclovir, 5 mg
  • J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
  • J0135Injection, adalimumab, 20 mgterminated
  • J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
  • J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
  • J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
  • J0139Injection, adalimumab, 1 mg
  • J0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated

Questions about J0132

What is HCPCS code J0132?

J0132 is a HCPCS Level II code for injection, acetylcysteine, 100 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0132?

The CMS HCPCS file marks J0132 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0132 paid under the physician fee schedule?

J0132 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026